SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-724610
Filing Date
2016-09-29
Accepted
2016-09-29 08:00:55
Documents
4
Period of Report
2016-09-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d449184d8k.htm 8-K 14570
2 EX-99.1 d449184dex991.htm EX-99.1 24627
3 GRAPHIC g449184g61e86.jpg GRAPHIC 4075
4 GRAPHIC g449184g74s22.jpg GRAPHIC 6778
  Complete submission text file 0001193125-16-724610.txt   55938
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-21898 | Film No.: 161908331
SIC: 2834 Pharmaceutical Preparations